Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis.
- Author:
Si ZHANG
1
;
Lin CAI
1
;
Heng ZHANG
1
;
Zheng ZHAO
1
;
Xiaoyang LIU
1
;
Yan ZHAO
1
;
Jianzhong ZHANG
1
Author Information
- Publication Type:Journal Article
- MeSH: Humans; Adalimumab/therapeutic use*; Psoriasis/drug therapy*; Antibodies, Monoclonal, Humanized/therapeutic use*; Treatment Outcome; Severity of Illness Index
- From: Chinese Medical Journal 2022;135(18):2248-2250
- CountryChina
- Language:English